What is the appropriate dosing for Bisoprolol (beta blocker)?

From the Guidelines

Bisoprolol should be started at a low dose of 1.25 mg once daily for heart failure, as recommended by the most recent guidelines 1. The dose can be gradually increased every 1-2 weeks based on patient response and tolerance.

• For heart failure, the target dose is 10 mg once daily, as indicated in the 2022 AHA/ACC/HFSA guideline for the management of heart failure 1.
• Bisoprolol should be taken at the same time each day, preferably in the morning, with or without food.
• Dose adjustments are necessary for patients with severe renal impairment (creatinine clearance <20 mL/min) or severe hepatic impairment, typically starting at 2.5 mg daily or every other day.
• Abrupt discontinuation should be avoided; instead, the dose should be gradually reduced over 1-2 weeks to prevent rebound hypertension or worsening angina.
• Bisoprolol works by blocking beta-1 adrenergic receptors in the heart, reducing heart rate, contractility, and blood pressure, making it effective for various cardiovascular conditions while causing fewer bronchospastic effects than non-selective beta-blockers. The recommended dosing is based on the latest evidence from the 2022 AHA/ACC/HFSA guideline, which prioritizes the use of bisoprolol in patients with heart failure with reduced ejection fraction (HFrEF) 1.

From the FDA Drug Label

The dose of bisoprolol fumarate must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2. 5 mg may be an appropriate starting dose. If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily

• Starting dose: 5 mg once daily, or 2.5 mg in some patients
• Dose titration: may be increased to 10 mg and then to 20 mg once daily if necessary
• Special populations:
  • Renal or hepatic impairment: initial daily dose of 2.5 mg, with caution in dose-titration 2
  • Geriatric patients: no adjustment necessary unless significant renal or hepatic dysfunction 2
  • Pediatric patients: no experience with bisoprolol fumarate, dose not established 2

From the Research

Bisoprolol Dosing

• The dosing of bisoprolol is not explicitly stated in the provided studies, but its efficacy in reducing mortality and improving heart failure outcomes is well-documented 3, 4, 5.
• Bisoprolol is often used in combination with ACE inhibitors, such as perindopril, to treat hypertension, stable coronary artery disease, and heart failure 6, 7.
• The combination of bisoprolol and ACE inhibitors has been shown to be effective in reducing cardiovascular risk and improving outcomes in patients with heart failure 7, 5.
• The choice of beta-blocker, including bisoprolol, is important, as benefit is not a class-effect, and some beta-blockers may have diminished efficacy due to intrinsic sympathomimetic activity (ISA) 4.
• Bisoprolol has been shown to be well-tolerated in patients with chronic heart failure, with common adverse events including dizziness, bradycardia, hypotension, and fatigue 3.

Combination Therapy

• The use of fixed combinations, such as bisoprolol and perindopril, can increase patient adherence to therapy and improve disease control 6, 7.
• Combining beta-blockers and ACE inhibitors provides complementary actions on the sympathetic nervous system and renin-angiotensin-aldosterone system, influencing cardiovascular risk and disease outcomes 7.
• The combination of beta-blockers and ACE inhibitors has been shown to be effective in reducing mortality and hospital readmissions in patients with chronic heart failure 5.

Clinical Applications

• Bisoprolol is indicated for the treatment of hypertension, stable coronary artery disease, and heart failure, particularly in patients with systolic dysfunction 6, 7.
• The use of bisoprolol in combination with ACE inhibitors is supported by clinical evidence, and this combination is considered a standard treatment option for patients with stable, moderate to severe chronic heart failure 3, 5.